Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2020 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (214)	12/11/2020 6:28:27 PM
From: jbogd	Read Replies (1) \| Respond to of 259

Bubba you had me worried. I was beaten up enough this week. Wuxi had a 3:1 Stock Spilt early yesterday Good Luck and Stay Safe JB

To: BulbaMan who wrote (214)	12/18/2020 9:46:24 PM
From: BulbaMan	Read Replies (1) \| Respond to of 259

12/18/2020 Contest update (Contest and Index YTDs are calculated from 1/3/2020 close.) Technetium has volunteered to be the scorekeeper for the 2021 Contest. Here’s the 2021 Contest link: Subject 60185. Time to start working on your 2021 Contest portfolio! Portfolio submission deadline is Sunday, January 3, 2021, Midnight, PST. As Trump’s days in the White House come to a close, we’re facing the dire consequences of his administration’s failures to protect us from Covid-19 and cyberattacks. The coronavirus is surging and we were hit with what’s being called the worst cyberattack in U.S. history. usatoday.com Despite the viral and cyber crises, the approval of two Covid-19 vaccines provided hope for the future. So, for this quadruple witching week, biotechs continued their climb skyward. (However, the second most popular Contest pick, FGEN, was down big after-hours as the FDA delayed the PDUFA for Roxadustat by 3 months.) At Friday’s close, the Contest median was up 36.53% YTD (vs. up 29.32% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 31.60% YTD (vs. up 27.01% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 58.02% YTD (vs. up 52.13% YTD a week ago), while the Nasdaq Composite Index (NCI) was up 41.40% YTD (vs. up 37.22% YTD a week ago). JBOG’s portfolio remains in first place with a large lead, finishing the week with a 221.26% YTD gain. FILO’s portfolio, up 172.11% YTD and DOUGH’s portfolio, up 121.37% YTD held on to second and third place. At Friday's close, 35 of the 42 Contest portfolios were in the green, with 23 beating the NBI and just 9 now beating the breathtaking SPSIBI. The 197 Contest stock picks have an average YTD gain of 40.29% with the median in the green with a YTD gain of 3.09%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy a safe and relaxing weekend biotechies. Merry Christmas to those who celebrate the holiday. Don’t forget to wear your mask and social distance. Peace & good health, Bulba 12/18/20 Rank Name Profit/Loss 1 JBOG 221,264 2 FILO 172,110 3 DOUGH 121,374 4 MASTER 101,257 5 BMAZ 94,672 6 OLIVIER 81,241 7 ERIK 76,133 8 TOMATO 73,698 9 IPOL 63,400 10 STEVEL 57,845 Week's Top 5 Gainers Symbol 12/11 12/18 Wk.%chg. ARVN 29.930 68.950 130.37% ARYC 0.001 0.002 87.50% KDNY 13.320 19.060 43.09% VERU 6.355 8.805 38.55% MGTX 12.400 17.080 37.74% Week's Worst 5 Losers Symbol 12/11 12/18 Wk.%chg. ARPO 2.250 1.000 -55.56% AGN.CN 0.435 0.240 -44.83% MIRM 25.450 17.450 -31.43% SCYX 7.870 6.210 -21.09% RKDA 3.050 2.530 -17.05%